In a small case series, Burnett and colleagues [18] showed that daily PDE5 inhibitor therapy reduced ischemic priapism episodes in men with stuttering priapism, either idiopathic or due to sickle-cell disease, without modifying erectile function. Here, PDE5A is linked to sickle cell disease.